We intend to explore the role of circulating PD‐1 (+) cells in tumor immune evasion in PTCL patients and the mechanism of chidamide as a regulator of immune‐associated medicine on PD‐1 (+) cells. Here, PDCD1 is linked to mature T-cell and NK-cell non-Hodgkin lymphoma.